153 related articles for article (PubMed ID: 2545813)
1. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice.
Carlsson M; Carlsson A
J Neural Transm; 1989; 77(1):65-71. PubMed ID: 2545813
[TBL] [Abstract][Full Text] [Related]
2. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice.
Carlsson M; Carlsson A
J Neural Transm; 1989; 75(3):221-6. PubMed ID: 2538557
[TBL] [Abstract][Full Text] [Related]
3. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.
Okuyama S; Imagawa Y; Tomisawa K
Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909
[TBL] [Abstract][Full Text] [Related]
4. Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice.
Svensson A; Carlsson ML; Carlsson A
J Neural Transm Gen Sect; 1995; 101(1-3):127-48. PubMed ID: 8695043
[TBL] [Abstract][Full Text] [Related]
5. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems.
Carlsson M; Svensson A
Pharmacol Biochem Behav; 1990 May; 36(1):45-50. PubMed ID: 2161545
[TBL] [Abstract][Full Text] [Related]
6. Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.
Svensson A; Carlsson A; Carlsson ML
J Neural Transm Gen Sect; 1992; 90(3):199-217. PubMed ID: 1363051
[TBL] [Abstract][Full Text] [Related]
7. Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine.
Carlsson M; Carlsson A
J Neural Transm Park Dis Dement Sect; 1989; 1(4):317-22. PubMed ID: 2557047
[TBL] [Abstract][Full Text] [Related]
8. The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice.
Carlsson M; Svensson A
Life Sci; 1990; 47(19):1729-36. PubMed ID: 2147454
[TBL] [Abstract][Full Text] [Related]
9. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
Dereń-Wesołek A; Maj J
Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
[TBL] [Abstract][Full Text] [Related]
10. Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.
Maj J; Skuza G; Rogóz Z
J Neural Transm Park Dis Dement Sect; 1993; 6(1):53-62. PubMed ID: 8105798
[TBL] [Abstract][Full Text] [Related]
11. Ethanol behaves as an NMDA antagonist with respect to locomotor stimulation in monoamine-depleted mice.
Carlsson ML; Engberg G
J Neural Transm Gen Sect; 1992; 87(2):155-60. PubMed ID: 1558743
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.
Carlsson M; Svensson A; Carlsson A
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):568-73. PubMed ID: 1682816
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
Hiramatsu M; Cho AK; Nabeshima T
Eur J Pharmacol; 1989 Aug; 166(3):359-66. PubMed ID: 2553433
[TBL] [Abstract][Full Text] [Related]
14. Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice.
Carlsson ML; Engberg G; Carlsson A
J Neural Transm Gen Sect; 1994; 95(3):223-33. PubMed ID: 7865177
[TBL] [Abstract][Full Text] [Related]
15. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
Strömbom U
Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
[TBL] [Abstract][Full Text] [Related]
16. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
[TBL] [Abstract][Full Text] [Related]
17. Locomotor hyperactivity induced by MK-801 in rats.
Maj J; Rogóz Z; Skuza G
Pol J Pharmacol Pharm; 1991; 43(6):449-58. PubMed ID: 1687944
[TBL] [Abstract][Full Text] [Related]
18. MK-801-induced stereotypy and its antagonism by neuroleptic drugs.
Tiedtke PI; Bischoff C; Schmidt WJ
J Neural Transm Gen Sect; 1990; 81(3):173-82. PubMed ID: 1975747
[TBL] [Abstract][Full Text] [Related]
19. Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801.
Goodwin P; Starr BS; Starr MS
J Neural Transm Park Dis Dement Sect; 1992; 4(1):15-26. PubMed ID: 1531757
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice.
Svensson A; Carlsson M; Carlsson A
J Neural Transm Gen Sect; 1991; 85(1):69-77. PubMed ID: 1867840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
